N-phenylamidophosphoric acid | 1445-36-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-phenylamidophosphoric acid
• 英文别名: phenyl-amidophosphoric acid；Phenyl-amidophosphorsaeure；Phosphorsaeure-monoanilid；N-(Phenyl)-phosphoramidsaeure；N-Phenyl-phosphorsaeure-amid；N-Phenylphosphoramidicsaeure；Phenylphosphoramidic acid；anilinophosphonic acid
• CAS: 1445-36-9
• 化学式: C₆H₈NO₃P
• 分子量: 173.108
• InChiKey: MHDLAWFYLQAULB-UHFFFAOYSA-N

物化性质

• 熔点：
  276-277 °C (decomp)
• 沸点：
  369.3±25.0 °C(Predicted)
• 密度：
  1.551±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  69.6
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  N-Phenyl-aethylen-phosphoroamidat 在 氰化钠 作用下， 以 二甲基亚砜 为溶剂， 生成 N-phenylamidophosphoric acid
  参考文献：
  名称：

  Thuong,N.T.; Chabrier,P., Bulletin de la Societe Chimique de France, 1975, p. 2083 - 2088

  摘要：

  DOI：

文献信息

• GAS SEPARATION MEMBRANE, GAS SEPARATION MODULE, GAS SEPARATOR, AND GAS SEPARATION METHOD
  申请人：FUJIFILM Corporation

  公开号：US20180339275A1

  公开（公告）日：2018-11-29

  A gas separation membrane includes a gas separation layer containing a polyimide compound and the polyimide compound has a repeating unit represented by Formula (I). In Formula (I), R f1 , R f4 , R f5 , and R f8 each independently represent an alkyl group. R f2 , R f3 , R f6 , R f7 , and R f9 to R f16 each independently represent a hydrogen atom or a substituent, and at least one of R f2 , R f3 , R f6 , R f7 , and R f9 , . . . , or R f16 represents a specific polar group. A represents a single bond or a divalent linking group having a specific structure. R represents a mother nucleus having a specific structure.

  一种气体分离膜包括含有聚酰亚胺化合物的气体分离层，该聚酰亚胺化合物具有由公式（I）表示的重复单元。 在公式（I）中，R f1 、R f4 、R f5 和R f8 各自独立代表一个烷基团。R f2 、R f3 、R f6 、R f7 和R f9 至R f16 各自独立代表一个氢原子或一个取代基，且至少一个R f2 、R f3 、R f6 、R f7 、R f9 ，...，或R f16 代表一个特定的极性基团。A代表一个单键或具有特定结构的二价连接基团。R代表具有特定结构的母核。
• ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE
  申请人：INOUE Tetsuya

  公开号：US20080071122A1

  公开（公告）日：2008-03-20

  It is an object of the present invention to provide a novel compound useful as a constituent of an organic EL element and the use of the compound permits the realization of a highly practical organic EL element whose driving voltage is substantially low and which has a low leakage current. Accordingly, the present invention herein provides a fluoranthene compound represented by the following general formula (1): A-L-B  (1) wherein A and B each represent a monovalent group having a fluoranthene structure represented by the following general formula (2), provided that A is linked to the group L present in the general formula (1), at the carbon atom selected from those specified by the numerical values of 7 to 10 appearing in Formula (2) and that B is linked to the group L present in Formula (1), at the carbon atom selected from those specified by the numerical values of 1 to 6 appearing in Formula (2): wherein L is a member selected from the group consisting of a single bond, substituted or unsubstituted arylene groups each having 6 to 40 carbon atoms, divalent groups derived from substituted or unsubstituted arylamines each having 6 to 40 carbon atoms, divalent groups derived from substituted or unsubstituted heterocyclic rings each having 3 to 40 carbon atoms and substituted or unsubstituted ethenylene groups.

  本发明的目的是提供一种作为有机EL元件组分有用的新型化合物，该化合物的使用使得可以实现驱动电压实质上较低且具有低泄漏电流的高度实用的有机EL元件。因此，本发明在此提供一种由下述通用式（1）表示的芴烯化合物： A-L-B  (1) 其中A和B分别表示具有由下述通用式（2）表示的芴烯结构的一价基团，前提是A与通用式（1）中存在的L基团连接，在通用式（2）中出现的数值为7至10的碳原子中选择的碳原子上，并且B与通用式（1）中存在的L基团连接，在通用式（2）中出现的数值为1至6的碳原子中选择的碳原子上： 其中L是从以下组成的群体中选择的成员：单键，具有6至40个碳原子的取代或未取代芳基基团，由具有6至40个碳原子的取代或未取代芳胺衍生的二价基团，由具有3至40个碳原子的取代或未取代杂环戒指衍生的二价基团，以及取代或未取代乙烯基团。
• Method and compositions for identifying anti-HIV therapeutic compounds
  申请人：Arimilli N. Murty

  公开号：US20050239054A1

  公开（公告）日：2005-10-27

  Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.

  提供了一种识别含有羧酸酯或磷酸酯基团取代的抗HIV治疗化合物的方法。可以选择使用新型酶GS-7340酯水解酶对这类化合物库进行筛选。还提供了与GS-7340酯水解酶相关的组合物和方法。
• ORGANIC ELECTROLUMINESCENCE DEVICE
  申请人：FUKUZAKI Eiji

  公开号：US20120178928A1

  公开（公告）日：2012-07-12

  An organic electroluminescence device includes: a pair of electrodes; and at least one organic layer including a light emitting layer, the light emitting layer being provided between the pair of electrodes, wherein at least one layer of the at least one organic layer contains a compound represented by formula (1): wherein each of Z 11 and Z 12 independently represents an aromatic heterocyclic ring or an aromatic hydrocarbon ring; R 11 represents a hydrogen atom or a substituent, provided that a plurality of R 11 s are the same or different; m represents an integer of 1 or more; and L 1 represents a single bond or an m-valent linking group and is linked to any one of C atoms in R 11 , Z 11 and Z 12 , provided that when m is 1, L 1 does not exist.

  有机电致发光设备包括：一对电极；以及至少一个包括发光层的有机层，发光层位于一对电极之间，其中至少一个有机层包含由公式（1）表示的化合物： 其中，Z 11 和Z 12 各自独立地代表一个芳香杂环或一个芳香烃环；R 11 代表一个氢原子或一个取代基，多个R 11 可以相同或不同；m代表一个1或更多的整数；L 1 代表一个单键或一个m价的连接基团，并且连接到R 11 、Z 11 和Z 12 中的任意一个C原子上，当m为1时，L 1 不存在。
• [EN] NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSITIONS D'ACIDE NUCLÉIQUE-POLYPEPTIDE ET UTILISATIONS DE CELLES-CI
  申请人：AVIDITY BIOSCIENCES INC

  公开号：WO2020247782A1

  公开（公告）日：2020-12-10

  Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

  本文披露了包括与修饰的多核苷酸分子和聚合物结合的结合基团的组合物和药物配方。本文还描述了利用包括结合基团与多核苷酸分子和聚合物结合的组合物或药物配方治疗癌症的方法。